Journal
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE
Volume 7, Issue 1, Pages 83-89Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijpddr.2017.01.005
Keywords
Giardia; Drug discovery; Malaria Box; Image-based assay
Categories
Funding
- Griffith University [NSC1009, NSC1010]
Ask authors/readers for more resources
Giardia duodenalis is an intestinal parasite that causes giardiasis, a widespread human gastrointestinal disease. Treatment of giardiasis relies on a small arsenal of compounds that can suffer from limitations including side-effects, variable treatment efficacy and parasite drug resistance. Thus new anti-Giardia drug leads are required. The search for new compounds with anti-Giardia activity currently depends on assays that can be labour-intensive, expensive and restricted to measuring activity at a single time-point. Here we describe a new in vitro assay to assess anti-Giardia activity. This image-based assay utilizes the Perkin-Elmer Operetta((R)) and permits automated assessment of parasite growth at multiple time points without cell-staining. Using this new approach, we assessed the Malaria Box compound set for antiGiardia activity. Three compounds with sub-mu M activity (IC50 0.6-0.9 mu M) were identified as potential starting points for giardiasis drug discovery. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available